COVID-19: Transmission, prevention, and potential therapeutic opportunities

M Lotfi, MR Hamblin, N Rezaei - Clinica chimica acta, 2020 - Elsevier
The novel coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Despite intense …

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Nature microbiology, 2020 - nature.com
The present outbreak of a coronavirus-associated acute respiratory disease called
coronavirus disease 19 (COVID-19) is the third documented spillover of an animal …

Coronavirus disease 2019: What we know?

F He, Y Deng, W Li - Journal of medical virology, 2020 - Wiley Online Library
In late December 2019, a cluster of unexplained pneumonia cases has been reported in
Wuhan, China. A few days later, the causative agent of this mysterious pneumonia was …

Seasonality of respiratory viral infections

M Moriyama, WJ Hugentobler… - Annual review of …, 2020 - annualreviews.org
The seasonal cycle of respiratory viral diseases has been widely recognized for thousands
of years, as annual epidemics of the common cold and influenza disease hit the human …

[HTML][HTML] SARS-CoV-2 in wastewater: State of the knowledge and research needs

M Kitajima, W Ahmed, K Bibby, A Carducci… - Science of the total …, 2020 - Elsevier
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a Public Health …

An overview of COVID-19

Y Shi, G Wang, X Cai, J Deng, L Zheng… - Journal of Zhejiang …, 2020 - pmc.ncbi.nlm.nih.gov
Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection emerged in Wuhan City, Hubei Province, China in December 2019. By Feb. 11 …

Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020

JA Backer, D Klinkenberg, J Wallinga - Eurosurveillance, 2020 - pmc.ncbi.nlm.nih.gov
A novel coronavirus (2019-nCoV) is causing an outbreak of viral pneumonia that started in
Wuhan, China. Using the travel history and symptom onset of 88 confirmed cases that were …

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

TP Sheahan, AC Sims, S Zhou, RL Graham… - Science translational …, 2020 - science.org
Coronaviruses (CoVs) traffic frequently between species resulting in novel disease
outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative …

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Y Zhou, Y Hou, J Shen, Y Huang, W Martin, F Cheng - Cell discovery, 2020 - nature.com
Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus
(SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead …

Kinetics of viral load and antibody response in relation to COVID-19 severity

Y Wang, L Zhang, L Sang, F Ye, S Ruan, B Zhong… - The Journal of clinical …, 2020 - jci.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue …